A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

Clinical trial NCT02365948 · COMPLETED

Trial details

NCT number: NCT02365948
Sponsor: UCB Pharma SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2015-03-01
Primary completion: 2015-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.